On Friday, October 21, Jan De Backer, CEO of Fluidda, will present at the 23rd Deutsches Aerosol Therapie Symposium, which will be held at the Hyperion Hotel in Munich, Germany.
The German Aerosol Therapy Symposium is the science-based platform for presenting and discussing the latest research-based findings, technologies, and trends in aerosols in medicine, inhalation systems, and respiratory therapy.
Dr. De Backer will speak on the topic: Patient-specific computer models for inhalation therapy.
With FRI and CFD technology, the possibilities of tailoring inhalation therapy to specific groups of lung patients have significantly increased these days.
For more information on this topic, please consult our website.
#J-18808-Ljbffr
Kontaktperson:
FluidDa nv HR Team